NetworkNewsBreaks – EVIO, Inc. (EVIO) Highlights
Post# of 2022
EVIO, Inc. (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, this morning announced its financial and operating results for the fiscal year ended September 30, 2017. The company’s revenue for the 12-month period was roughly $3 million, marking a year-over-year increase of 438 percent. Per the update, the majority of this growth came from increased testing revenue, which was up 782 percent over the previous year. “2017 has been a pivotal year for EVIO, especially as we continued to scale the company to meet the industry’s increased needs for mandatory testing,” William Waldrop, chairman and chief executive officer of EVIO, stated in the news release. “We are extremely pleased with our results for the fiscal year 2017.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer